Cyclerion Therapeutics (CYCN) Payables (2018 - 2025)
Cyclerion Therapeutics (CYCN) recorded quarterly Payables of $508000.0 in Q4 2025, up 5.83% quarter-over-quarter from $480000.0 in Q3 2025, and up 30.26% on a YoY basis from $390000.0 in Q4 2024.
Cyclerion Therapeutics (CYCN) Payables (2018 - 2025) Analysis & Trends
Cyclerion Therapeutics' Payables history runs 8 years deep, the most recent figure standing at $508000.0 for Q4 2025.
- In Q4 2025, Payables rose 30.26% year-over-year to $508000.0; the TTM figure through Dec 2025 stood at $508000.0 (up 30.26% YoY), while the FY2025 annual figure was $508000.0, up 30.26% from the prior year.
- Payables was $508000.0 for Q4 2025 at Cyclerion Therapeutics, up from $480000.0 in the prior quarter.
- In the past five years, Payables ranged from a high of $4.9 million in Q2 2021 to a low of $304000.0 in Q3 2024.
- Historically, Payables has averaged $1.9 million across 5 years, with a median of $1.4 million in 2022.
- The sharpest annual moves came in 2021 and 2024: Payables surged 7703.39% in 2021, then plunged 81.12% in 2024.
- A 5-year view of Payables shows it stood at $1.8 million in 2021, then surged by 62.47% to $3.0 million in 2022, then plunged by 59.66% to $1.2 million in 2023, then slumped by 67.45% to $390000.0 in 2024, then surged by 30.26% to $508000.0 in 2025.
- The last three Payables figures came in at $508000.0 (Q4 2025), $480000.0 (Q3 2025), and $462000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 300,549.00 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 8.69 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 34.55 Mn |
| 10 | Cyclerion Therapeutics | 11.50 Mn | 8.26 Mn | - | 508,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 508,000.00 |
| Sep 30, 2025 | 480,000.00 |
| Jun 30, 2025 | 462,000.00 |
| Mar 31, 2025 | 483,000.00 |
| Dec 31, 2024 | 390,000.00 |
| Sep 30, 2024 | 304,000.00 |
| Jun 30, 2024 | 651,000.00 |
| Mar 31, 2024 | 741,000.00 |
| Dec 31, 2023 | 1.20 Mn |
| Sep 30, 2023 | 814,000.00 |
| Jun 30, 2023 | 1.86 Mn |
| Mar 31, 2023 | 3.93 Mn |
| Dec 31, 2022 | 2.97 Mn |
| Sep 30, 2022 | 1.65 Mn |
| Jun 30, 2022 | 2.77 Mn |
| Mar 31, 2022 | 2.52 Mn |
| Dec 31, 2021 | 1.83 Mn |
| Sep 30, 2021 | 4.68 Mn |
| Jun 30, 2021 | 4.90 Mn |
| Mar 31, 2021 | 4.60 Mn |